Your browser doesn't support javascript.
loading
Vitexin Induces Apoptosis in MCF-7 Breast Cancer Cells through the Regulation of Specific miRNAs Expression.
Najafipour, Reza; Momeni, Abdol Mabood; Mirmazloomi, Yousef; Moghbelinejad, Sahar.
Affiliation
  • Najafipour R; Genetics Research Center, University of Social Welfare and Rehabilitation Science, Tehran, Iran.
  • Momeni AM; Khatam Pathobiology and Genetics lab, Qazvin, Iran.
  • Mirmazloomi Y; School of Medicine, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Iran.
  • Moghbelinejad S; Research Institute for Prevention of Non-Communicable Diseases, Cellular and Molecular Research Centre, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Iran.
Int J Mol Cell Med ; 11(3): 197-206, 2022.
Article in En | MEDLINE | ID: mdl-37605736
ABSTRACT
In this research, we investigated microRNAs (miRNAs) expression profile in MCF-7 breast cancer cell line which treated with 150 µM vitexin. Profiling of miRNAs expression was performed using TaqMan MiRNA Array. Apoptosis was analyzed by flow cytometry and the expression of some genes involved in "anti-proliferative" signaling pathways were evaluated by western blotting and real time PCR methods. Twenty microRNAs were differentially expressed in vitexin treated cells compared to the control. Among them, let-7- b, c were up regulated while miRNA-17-5p was down regulated with highest score. Also, we detected the expression changes of mentioned miRNAs target genes as well as genes involved in caspase apoptosis pathways. Our results provide the first evidence that vitexin can effect miRNA expression in MCF-7 cells. Also based on our finding, vitexin can be an attractive miRNA mediated chemo preventive and therapeutic agent in breast cancer.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Mol Cell Med Year: 2022 Document type: Article Affiliation country: Irán

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Mol Cell Med Year: 2022 Document type: Article Affiliation country: Irán